SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-24-000034
Filing Date
2024-01-25
Accepted
2024-01-25 12:32:15
Documents
1
Effectiveness Date
2024-01-25

Document Format Files

Seq Description Document Type Size
1 8A_cert_AVBP.pdf CERT 111267
  Complete submission text file 0001354457-24-000034.txt   154473
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent Biopharma, Inc. (Filer) CIK: 0001868279 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-41929 | Film No.: 24560589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)